Loading the records…
Loading the records…
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, BROADWOOD PARTNERS, L.P., holds the title of 10% Owner at Insight Molecular Diagnostics Inc..
On 2026-11-17, the insider transacted 3,428,571 shares.The shares were transacted at a weighted average price of $1.75 per share, resulting in a total market-relevant value of $6.0M.
BROADWOOD PARTNERS, L.P. (10% Owner) bought $6.0M of $IMDX
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.